dc.contributor.author | Tran-Dinh, Alexy | |
dc.contributor.author | Castier, Yves | |
dc.contributor.author | Guyard, Alice | |
dc.contributor.author | Longrois, Dan | |
dc.contributor.author | Silverstein, Adam M. | |
dc.contributor.author | Norel, Xavier | |
dc.contributor.author | Ozen, Gulsev | |
dc.contributor.author | Amgoud, Yasmine | |
dc.contributor.author | Senbel, Amira | |
dc.contributor.author | Bouhadoun, Amel | |
dc.contributor.author | Abdelazeem, Heba | |
dc.contributor.author | Savane, Ines | |
dc.contributor.author | Manikpurage, Hasanga D. | |
dc.contributor.author | Mani, Salma | |
dc.date.accessioned | 2021-12-10T13:06:10Z | |
dc.date.available | 2021-12-10T13:06:10Z | |
dc.identifier.citation | Amgoud Y., Senbel A., Bouhadoun A., Abdelazeem H., Ozen G., Savane I., Manikpurage H. D. , Mani S., Tran-Dinh A., Castier Y., et al., "In search of pulmonary hypertension treatments: Effect of 17 beta-estradiol on PGI(2) pathway in human pulmonary artery", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, cilt.172, 2021 | |
dc.identifier.issn | 0952-3278 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_ee8e28c2-25a7-4690-be25-b7abe7a49aa1 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/175412 | |
dc.identifier.uri | https://doi.org/10.1016/j.plefa.2021.102321 | |
dc.description.abstract | Introduction: Prostacyclin (PGI(2)) is synthetized by PGI(2) synthase (PGIS) and induces vasorelaxation via activation of cyclic AMP (cAMP) generating IP-receptor. Several components of the PGI(2) signaling pathway are reduced in patients with pulmonary hypertension (PH). | |
dc.language.iso | eng | |
dc.subject | Aging | |
dc.subject | General Biochemistry, Genetics and Molecular Biology | |
dc.subject | Biochemistry | |
dc.subject | ENDOKRİNOLOJİ VE METABOLİZMA | |
dc.subject | Endocrinology, Diabetes and Metabolism | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Structural Biology | |
dc.subject | Klinik Tıp | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | HÜCRE BİYOLOJİSİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Histoloji-Embriyoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Endokrinoloji ve Metabolizma Hastalıkları | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Sitogenetik | |
dc.subject | Temel Bilimler | |
dc.subject | Biochemistry, Genetics and Molecular Biology (miscellaneous) | |
dc.subject | Endocrinology | |
dc.subject | Clinical Biochemistry | |
dc.subject | Cell Biology | |
dc.subject | Cancer Research | |
dc.subject | Molecular Biology | |
dc.subject | Endocrine and Autonomic Systems | |
dc.subject | Drug Discovery | |
dc.title | In search of pulmonary hypertension treatments: Effect of 17 beta-estradiol on PGI(2) pathway in human pulmonary artery | |
dc.type | Makale | |
dc.relation.journal | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | |
dc.contributor.department | Hopital Universitaire Bichat-Claude Bernard - APHP , , | |
dc.identifier.volume | 172 | |
dc.contributor.firstauthorID | 2725299 | |